Virtual Clinical Trials Find Bigger Voice As COVID-19 Forces Pharma Rethink
Enforced Postponement Of Some Clinical Trials Has Compelled Therapy Developers To Seek Alternatives Routes
Executive Summary
The use of virtual, real-time and at-home testing to provide clinical trials data has been steadily gaining the interest of the health care industry. COVID-19 has put this opportunity into sharper focus, says CNS trials technology developer Cambridge Cognition, which is now adding a voice option to its portfolio.